Entries by melindaroberts

Targeted Therapy and/or Immunotherapy for Cancer

Paul R. Billings MD, PhD, Internist, Clinical Geneticist, and Immunologist: Founder and Executive Chairman, PlumCare LLC; Chairman, Biological Dynamics Inc; Co-Founder and Chief Medical Officer, Omicia; Principal, Bethesda Group LLC; […]

Managing Metastatic Colorectal Cancer

Bassel El-Rayes, MD, Professor and Vice Chair for Clinical Research, Department of Hematology and Medical Oncology, Associate Director for Clinical Research, and Director of the Gastrointestinal Oncology Program Winship Cancer […]

Compassionate Use of Investigational Drugs

Arthur L Caplan, PhD Director, Division of Medical Ethics, NYU Langone Medical Center. Amrit Ray MD, MBA, Chief Medical Officer, Janssen Pharmaceutical Companies of Johnson & Johnson. Q: What is the ethical […]

Making NGS Work for Oncologists

Smruti Vidwans, PhD, Chief Science Officer at CollabRx Q: Your group has recently described an Actionability Framework for designing treatment strategies for cancers that are characterized by mutations. What is […]

Treating Metastatic Malignant Melanoma

Keith Flaherty, MD, Associate Professor of Medicine, Harvard Medical School; Director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital. Q: What is your basic approach to handling a new young […]

Introducing a New CollabRx Blog

George D Lundberg, MD, Editor in Chief and Chief Medical Officer & Denise Bartolome, Managing Editor and Webmaster   Q: Why are we starting The CollabRx Blog? A: With our new blog, […]